Immunotherapy trials in metastatic colorectal cancer | Download Table
ASCO GI 2022: Trial evaluating immunotherapy in neoadjuvant setting for the treatment of locally advanced rectal cancer
Clinical trials of immunotherapy in colorectal cancer | Download Scientific Diagram
Immunotherapy Combination Approved for Colorectal Cancer - NCI
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy - ScienceDirect
Colorectal Cancer Clinical Trials | Fight Colorectal Cancer
Advances in immunotherapy for colorectal cancer: a review | Semantic Scholar
Frontiers | Clinical Application of Adaptive Immune Therapy in MSS Colorectal Cancer Patients
Patients with MSI-High Colorectal Cancer Sought for Immunotherapy Trial – Consult QD
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success?: Molecular Therapy - Oncolytics
Immunotherapy for Microsatellite Stable Colorectal Cancers: Challenges and Novel Therapeutic Avenues | American Society of Clinical Oncology Educational Book
Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer | NEJM
View of The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation | Annals of Gastroenterology
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal 'Immunoablative' Neoadjuvant Immunotherapy Clinical Trial | Memorial Sloan Kettering Cancer Center
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
Immunotherapy in colorectal cancer: rationale, challenges and potential | Nature Reviews Gastroenterology & Hepatology
Advances and new frontiers for immunotherapy in colorectal cancer: Setting the stage for neoadjuvant success? - ScienceDirect
Cancers | Free Full-Text | Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
Frontiers | Colorectal cancer vaccines: The current scenario and future prospects
Key immunotherapy trials in metastatic colorectal cancer (CRC). | Download Table
Cells | Free Full-Text | Immunotherapy, Inflammation and Colorectal Cancer
Immune Checkpoint Blockade Therapy in Patients With Colorectal Cancer Harboring Microsatellite Instability/Mismatch Repair Deficiency in 2022 | American Society of Clinical Oncology Educational Book
Neoadjuvant PD-1 blockade: a promising nonoperative strategy for mismatch repair–deficient, locally advanced rectal cancer | Signal Transduction and Targeted Therapy
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers | Nature Medicine
Rectal Cancer Disappears After Experimental Use of Immunotherapy | Memorial Sloan Kettering Cancer Center
Oncolytic viroimmunotherapy for colon cancer in clinical trials. | Download Scientific Diagram
